UNSPSC 51284505: Aztreonam lysine

This classification denotes a beta-lactam antibiotic with the molecular formula C13H17N5O8S2.C6H14N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XNM7LT65NP. European Medicines Agency schedules aztreonam lysine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30777. The term aztreonam lysine is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule aztreonam lysine under HS 29419000 and SITC 54139.

As of Q4 2014, AZTREONAM LYSINE remains US FDA's Preferred Term for this commodity. Aztreonam lysine bears US NLM identifiers UMLS ID C2698293 and NCI Concept Code C76021. SMILES: C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)/C(=N\OC(C)(C)C(=O)O)/C2CSC(N2)N.C(CCN)C[C@@H](C(=O)O)N.

UNSPSC 51284505 Aztreonam lysine is a Commodity code assigned to a specific pharmaceutical product, but the recent state and local contract opportunities tagged under this code show minimal alignment with the code's nominal scope. The opportunities posted under 51284505 reflect broader pharmaceutical procurement activity — including naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, emergency medical and first aid supplies, and generic multi-source pharmaceuticals and OTC products — rather than solicitations for aztreonam lysine specifically. State and local governments use this code to buy a wide range of pharmaceutical products and emergency medical supplies through competitive bidding processes, cooperative purchasing agreements, and requests for information designed to establish framework contracts with manufacturers and distributors.

Issuing bodies include county health departments (Seminole County, Florida), state health agencies (Texas HHS Commission), municipal fire departments (City of Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities across multiple jurisdictions including Oregon). Recent activity spans Florida, Texas, Minnesota, and Oregon. Representative solicitations include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023; the City of Tampa's invitation to bid for 169 line items of medical and first aid supplies for the Fire Department Rescue Division (estimated contract value $700,000, designated as a sheltered market for certified Small Local Business Enterprises) with a response deadline of March 13, 2026; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026. The code shows little genuine pharmaceutical-specific procurement activity aligned to aztreonam lysine itself.